INIS (Radnostix) Long-Term Debt: $1.72 Mil (As of Mar. 2026)


What is Radnostix Long-Term Debt?

Radnostix INIS -3.19% Long-Term Debt is $1.72 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Radnostix's Long-Term Debt for the quarter that ended in Mar. 2026 was $1.72 Mil.

Radnostix's quarterly Long-Term Debt declined from Sep. 2025 ($1.80 Mil) to Dec. 2025 ($1.77 Mil) and declined from Dec. 2025 ($1.77 Mil) to Mar. 2026 ($1.72 Mil).

Radnostix's annual Long-Term Debt increased from Dec. 2023 ($1.89 Mil) to Dec. 2024 ($1.90 Mil) but then declined from Dec. 2024 ($1.90 Mil) to Dec. 2025 ($1.77 Mil).


Radnostix  (OTCPK:INIS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Radnostix Long-Term Debt Related Terms


Radnostix Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Radnostix's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radnostix Long-Term Debt Chart

Radnostix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 1.03 1.89 1.90 1.77

Radnostix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 1.84 1.80 1.77 1.72
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $1.72 Mil mean?
Radnostix (INIS) has a Long-Term Debt of $1.72 Mil as of Mar. 2026.
Is Radnostix's Long-Term Debt too high?
Radnostix's current Long-Term Debt is $1.72 Mil.
How does Radnostix's Long-Term Debt compare to SCYX and BTAI?
Radnostix's Long-Term Debt of $1.72 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Radnostix's current Long-Term Debt is $1.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radnostix stock overvalued right now?
Based on GuruFocus' analysis, Radnostix (INIS) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.07 — trading 33.7% above its estimated fair value. The current Long-Term Debt is $1.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Radnostix (INIS), the current Long-Term Debt is $1.72 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Radnostix Business Description

Address 4137 Commerce Circle, Idaho Falls, ID, USA, 83401
Radnostix Inc manufactures a wide range of radioisotope-focused products used in a variety of medical and industrial applications. The company produces generic sodium iodide I-131 drug product, produces a variety of cobalt-60 products, and is in development to manufacture and sell medical devices for the nuclear medicine industry. Its business consists of five reportable segments, which include: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The majority of the revenue is derived from the Theranostics Products segment, which produces and distributes various isotopically pure radiopharmaceuticals, APIs, and radiochemicals for medical, industrial, and research applications.